Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2f1
|
ENSMUSG00000069171.7 | nuclear receptor subfamily 2, group F, member 1 |
Nr4a1
|
ENSMUSG00000023034.6 | nuclear receptor subfamily 4, group A, member 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_78189847_78190042 | Nr2f1 | 499 | 0.717055 | -0.61 | 8.6e-07 | Click! |
chr13_78191875_78192156 | Nr2f1 | 1572 | 0.288607 | -0.61 | 9.8e-07 | Click! |
chr13_78189607_78189758 | Nr2f1 | 761 | 0.549929 | -0.60 | 1.2e-06 | Click! |
chr13_78197725_78197901 | Nr2f1 | 117 | 0.619951 | -0.60 | 1.4e-06 | Click! |
chr13_78186875_78187026 | Nr2f1 | 3493 | 0.160506 | -0.58 | 3.0e-06 | Click! |
chr15_101254222_101254612 | Nr4a1 | 148 | 0.916170 | -0.44 | 7.3e-04 | Click! |
chr15_101277343_101277667 | Nr4a1 | 4644 | 0.110755 | -0.33 | 1.3e-02 | Click! |
chr15_101246921_101247117 | Nr4a1 | 7250 | 0.101712 | 0.29 | 3.1e-02 | Click! |
chr15_101246672_101246858 | Nr4a1 | 7504 | 0.101064 | 0.29 | 3.2e-02 | Click! |
chr15_101242717_101242959 | Nr4a1 | 11431 | 0.094135 | 0.23 | 9.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_127508848_127510720 | 30.07 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr4_108066710_108066871 | 28.00 |
Scp2 |
sterol carrier protein 2, liver |
4573 |
0.16 |
chr19_34819633_34819818 | 24.82 |
Mir107 |
microRNA 107 |
1048 |
0.43 |
chr4_3373427_3373611 | 22.44 |
Gm11784 |
predicted gene 11784 |
13327 |
0.2 |
chr12_78910545_78910709 | 21.65 |
Plek2 |
pleckstrin 2 |
3663 |
0.22 |
chr6_87873042_87873340 | 20.23 |
Copg1 |
coatomer protein complex, subunit gamma 1 |
14623 |
0.08 |
chr7_3073202_3073372 | 19.80 |
Gm3104 |
predicted gene 3104 |
12714 |
0.1 |
chr6_40795188_40795349 | 19.71 |
Mgam2-ps |
maltase-glucoamylase 2, pseudogene |
8327 |
0.18 |
chr4_133879094_133879516 | 19.34 |
Gm12985 |
predicted gene 12985 |
3822 |
0.14 |
chr4_150685197_150685518 | 19.34 |
Gm16079 |
predicted gene 16079 |
6565 |
0.21 |
chr6_52163698_52164573 | 19.27 |
Hoxa2 |
homeobox A2 |
696 |
0.33 |
chr4_119589443_119589736 | 19.09 |
Foxj3 |
forkhead box J3 |
31753 |
0.1 |
chr3_65658208_65659857 | 18.84 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr5_90641326_90641502 | 18.81 |
Rassf6 |
Ras association (RalGDS/AF-6) domain family member 6 |
757 |
0.63 |
chr2_163575250_163575556 | 18.75 |
Hnf4a |
hepatic nuclear factor 4, alpha |
25320 |
0.11 |
chr14_121423066_121423250 | 18.64 |
Gm33299 |
predicted gene, 33299 |
32604 |
0.14 |
chr11_94589805_94589967 | 18.32 |
Acsf2 |
acyl-CoA synthetase family member 2 |
11883 |
0.11 |
chr5_141852252_141852469 | 18.11 |
Sdk1 |
sidekick cell adhesion molecule 1 |
4427 |
0.36 |
chr11_51767849_51768134 | 18.08 |
Sar1b |
secretion associated Ras related GTPase 1B |
4297 |
0.17 |
chr6_136781746_136781912 | 18.02 |
Gucy2c |
guanylate cyclase 2c |
64 |
0.95 |
chr9_70671067_70671233 | 17.68 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
7847 |
0.17 |
chr2_173152448_173152646 | 17.61 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
501 |
0.77 |
chr1_191641396_191641769 | 17.56 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chr17_66881067_66881230 | 17.43 |
Gm49940 |
predicted gene, 49940 |
18908 |
0.16 |
chr13_107063669_107063832 | 17.38 |
Gm31452 |
predicted gene, 31452 |
55 |
0.97 |
chr18_68274714_68274873 | 17.17 |
Mir7219 |
microRNA 7219 |
13820 |
0.15 |
chr14_25867946_25868151 | 17.08 |
Anxa11os |
annexin A11, opposite strand |
2218 |
0.21 |
chr11_50139698_50139860 | 17.02 |
Tbc1d9b |
TBC1 domain family, member 9B |
4352 |
0.13 |
chr11_90231759_90231975 | 16.53 |
Mmd |
monocyte to macrophage differentiation-associated |
17589 |
0.17 |
chr9_70934835_70934986 | 16.42 |
Lipc |
lipase, hepatic |
102 |
0.97 |
chr6_87875662_87875822 | 16.42 |
Copg1 |
coatomer protein complex, subunit gamma 1 |
12072 |
0.08 |
chr18_76171650_76171801 | 16.41 |
Mir6358 |
microRNA 6358 |
1173 |
0.51 |
chr2_115520519_115520722 | 16.40 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
7124 |
0.25 |
chr16_97497682_97498061 | 16.33 |
Gm24777 |
predicted gene, 24777 |
1151 |
0.37 |
chr7_101064633_101064988 | 16.31 |
Gm5735 |
predicted gene 5735 |
3335 |
0.2 |
chr11_69718782_69718958 | 16.28 |
Gm12307 |
predicted gene 12307 |
11714 |
0.05 |
chr11_117780269_117780842 | 16.09 |
Tmc6 |
transmembrane channel-like gene family 6 |
66 |
0.93 |
chr19_3895109_3895657 | 16.08 |
Tcirg1 |
T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
1847 |
0.16 |
chr7_25450023_25450174 | 16.02 |
Gm15495 |
predicted gene 15495 |
6635 |
0.11 |
chr16_13276181_13276648 | 15.95 |
Mrtfb |
myocardin related transcription factor B |
11338 |
0.26 |
chr16_20730260_20730435 | 15.95 |
Thpo |
thrombopoietin |
204 |
0.85 |
chr13_106893878_106894037 | 15.93 |
Ipo11 |
importin 11 |
31193 |
0.12 |
chr1_86406983_86407186 | 15.85 |
Nmur1 |
neuromedin U receptor 1 |
8894 |
0.1 |
chr18_50028238_50028565 | 15.79 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2617 |
0.3 |
chr11_11729316_11729485 | 15.56 |
Gm12000 |
predicted gene 12000 |
32961 |
0.14 |
chr17_12671062_12671356 | 15.48 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
4487 |
0.2 |
chr5_124076623_124076825 | 15.45 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
2407 |
0.16 |
chr9_46235300_46235495 | 15.37 |
Apoc3 |
apolipoprotein C-III |
72 |
0.93 |
chr7_80971099_80971312 | 15.32 |
Gm18782 |
predicted gene, 18782 |
8688 |
0.11 |
chr9_67118947_67119232 | 15.11 |
Gm19299 |
predicted gene, 19299 |
14471 |
0.15 |
chr5_100568224_100568403 | 14.96 |
Plac8 |
placenta-specific 8 |
3879 |
0.16 |
chr19_10657832_10658033 | 14.96 |
Vwce |
von Willebrand factor C and EGF domains |
57 |
0.95 |
chr6_72279340_72279553 | 14.92 |
Sftpb |
surfactant associated protein B |
25164 |
0.11 |
chr1_184781740_184782518 | 14.77 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
26724 |
0.12 |
chr7_100544559_100544743 | 14.75 |
Gm39059 |
predicted gene, 39059 |
1471 |
0.21 |
chr15_67014626_67015037 | 14.73 |
Gm31342 |
predicted gene, 31342 |
25227 |
0.17 |
chr16_21825862_21826032 | 14.73 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
5 |
0.96 |
chr6_113661937_113662175 | 14.70 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
6794 |
0.08 |
chr18_38777858_38778144 | 14.68 |
Gm8302 |
predicted gene 8302 |
5654 |
0.22 |
chr2_32418807_32418958 | 14.66 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1052 |
0.33 |
chr10_127658232_127658422 | 14.66 |
Stat6 |
signal transducer and activator of transcription 6 |
1073 |
0.29 |
chr9_110668886_110669048 | 14.57 |
Ccdc12 |
coiled-coil domain containing 12 |
2042 |
0.19 |
chr17_79918454_79919008 | 14.57 |
Gm6552 |
predicted gene 6552 |
15841 |
0.16 |
chr7_141517720_141517895 | 14.36 |
Gm45416 |
predicted gene 45416 |
796 |
0.42 |
chr11_83792446_83792598 | 14.36 |
Gm11434 |
predicted gene 11434 |
7942 |
0.12 |
chr7_123353967_123354476 | 14.35 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
15563 |
0.17 |
chr8_122329580_122330425 | 14.34 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr8_70193232_70193519 | 14.24 |
Tmem161a |
transmembrane protein 161A |
12836 |
0.09 |
chr8_25710669_25710867 | 14.24 |
Plpp5 |
phospholipid phosphatase 5 |
9269 |
0.09 |
chr7_103826228_103826489 | 14.23 |
Hbb-bs |
hemoglobin, beta adult s chain |
1367 |
0.17 |
chr17_80128584_80128755 | 14.20 |
Galm |
galactose mutarotase |
1198 |
0.43 |
chr11_44509325_44509652 | 14.19 |
Rnf145 |
ring finger protein 145 |
9476 |
0.16 |
chr1_140415769_140416105 | 14.16 |
Kcnt2 |
potassium channel, subfamily T, member 2 |
26999 |
0.25 |
chr1_156073229_156073418 | 14.14 |
Tor1aip2 |
torsin A interacting protein 2 |
10110 |
0.17 |
chr3_131264205_131264396 | 14.04 |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
7724 |
0.17 |
chr7_79842295_79842494 | 14.04 |
Anpep |
alanyl (membrane) aminopeptidase |
42 |
0.96 |
chr15_76690078_76690406 | 14.01 |
Ppp1r16a |
protein phosphatase 1, regulatory subunit 16A |
165 |
0.86 |
chr5_119337927_119338125 | 14.00 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
40781 |
0.19 |
chr16_49800061_49800448 | 13.96 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
279 |
0.89 |
chr15_95883474_95883993 | 13.90 |
Gm25070 |
predicted gene, 25070 |
3916 |
0.23 |
chr1_161301867_161302018 | 13.89 |
Gm19057 |
predicted gene, 19057 |
2928 |
0.26 |
chr3_137969141_137969487 | 13.87 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12216 |
0.12 |
chr7_110990768_110990956 | 13.86 |
Mrvi1 |
MRV integration site 1 |
8401 |
0.19 |
chr13_95626792_95626955 | 13.84 |
F2r |
coagulation factor II (thrombin) receptor |
8386 |
0.16 |
chr1_131992847_131992998 | 13.79 |
Slc45a3 |
solute carrier family 45, member 3 |
13958 |
0.12 |
chr17_26616763_26616955 | 13.79 |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
3409 |
0.16 |
chr2_28601758_28601945 | 13.75 |
Gm22824 |
predicted gene, 22824 |
6344 |
0.11 |
chr2_126575507_126575676 | 13.75 |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
10831 |
0.18 |
chrX_93089100_93089251 | 13.66 |
1700003E24Rik |
RIKEN cDNA 1700003E24 gene |
66979 |
0.11 |
chr6_113690640_113690849 | 13.62 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
1 |
0.91 |
chr1_88408427_88408581 | 13.61 |
Spp2 |
secreted phosphoprotein 2 |
1098 |
0.47 |
chr5_114922913_114923574 | 13.59 |
Oasl1 |
2'-5' oligoadenylate synthetase-like 1 |
3 |
0.5 |
chr19_55232114_55232505 | 13.57 |
Gucy2g |
guanylate cyclase 2g |
8927 |
0.17 |
chr7_16046417_16047443 | 13.50 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr13_3106664_3106826 | 13.43 |
Gm46400 |
predicted gene, 46400 |
12817 |
0.11 |
chr8_22414458_22414615 | 13.42 |
Mrps31 |
mitochondrial ribosomal protein S31 |
3138 |
0.13 |
chr5_24969237_24969541 | 13.40 |
1500035N22Rik |
RIKEN cDNA 1500035N22 gene |
16453 |
0.17 |
chr4_136214938_136215135 | 13.38 |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
8671 |
0.14 |
chr10_128965049_128965401 | 13.33 |
Mettl7b |
methyltransferase like 7B |
4237 |
0.1 |
chr15_7167953_7168132 | 13.31 |
Lifr |
LIF receptor alpha |
13689 |
0.25 |
chr19_43782049_43782382 | 13.29 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
23 |
0.97 |
chr19_40500083_40500248 | 13.27 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
12419 |
0.18 |
chr5_36726254_36726643 | 13.27 |
Gm43701 |
predicted gene 43701 |
22170 |
0.11 |
chr9_106724913_106725237 | 13.25 |
Rad54l2 |
RAD54 like 2 (S. cerevisiae) |
2204 |
0.26 |
chr17_48738837_48738988 | 13.24 |
Gm45330 |
predicted gene 45330 |
166 |
0.97 |
chr1_85960049_85960213 | 13.17 |
Gpr55 |
G protein-coupled receptor 55 |
876 |
0.47 |
chr2_164437602_164437989 | 13.13 |
Sdc4 |
syndecan 4 |
5391 |
0.09 |
chr14_63232929_63233104 | 13.11 |
Gata4 |
GATA binding protein 4 |
12232 |
0.16 |
chr8_79372746_79372903 | 13.11 |
Smad1 |
SMAD family member 1 |
16146 |
0.17 |
chr16_93726325_93726495 | 13.05 |
Dop1b |
DOP1 leucine zipper like protein B |
3689 |
0.2 |
chr4_134760766_134761128 | 13.03 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
7077 |
0.2 |
chr9_45136890_45137081 | 12.93 |
Gm10684 |
predicted gene 10684 |
1379 |
0.2 |
chr4_108369351_108369502 | 12.92 |
Shisal2a |
shisa like 2A |
13923 |
0.12 |
chr2_155101774_155102009 | 12.89 |
2310005A03Rik |
RIKEN cDNA 2310005A03 gene |
1810 |
0.27 |
chr3_19978461_19978612 | 12.83 |
Cp |
ceruloplasmin |
2092 |
0.3 |
chr11_18885692_18886198 | 12.73 |
Gm37818 |
predicted gene, 37818 |
1846 |
0.29 |
chr4_46432413_46432710 | 12.69 |
Gm12443 |
predicted gene 12443 |
12259 |
0.12 |
chr2_44920846_44920997 | 12.66 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
6228 |
0.29 |
chr17_83645321_83645506 | 12.66 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
13518 |
0.24 |
chr9_67040893_67041308 | 12.66 |
Tpm1 |
tropomyosin 1, alpha |
2609 |
0.26 |
chr11_87749523_87749886 | 12.62 |
Mir142hg |
Mir142 host gene (non-protein coding) |
5873 |
0.09 |
chr12_110974333_110974713 | 12.49 |
Ankrd9 |
ankyrin repeat domain 9 |
3732 |
0.14 |
chr9_46086938_46087108 | 12.47 |
Sik3 |
SIK family kinase 3 |
36107 |
0.13 |
chr13_94328203_94328399 | 12.47 |
Gm5668 |
predicted gene 5668 |
28442 |
0.11 |
chr1_161958066_161958217 | 12.40 |
4930558K02Rik |
RIKEN cDNA 4930558K02 gene |
11007 |
0.13 |
chr6_113054865_113055022 | 12.34 |
Thumpd3 |
THUMP domain containing 3 |
3007 |
0.14 |
chr1_191640174_191640469 | 12.33 |
Gm37349 |
predicted gene, 37349 |
42674 |
0.11 |
chr17_29670052_29670314 | 12.26 |
Cmtr1 |
cap methyltransferase 1 |
6046 |
0.12 |
chr7_19012999_19013194 | 12.20 |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
9052 |
0.07 |
chr15_9114613_9115328 | 12.19 |
Nadk2 |
NAD kinase 2, mitochondrial |
11982 |
0.18 |
chr5_122137161_122137351 | 12.15 |
Ccdc63 |
coiled-coil domain containing 63 |
806 |
0.53 |
chr11_60810507_60810675 | 12.13 |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
500 |
0.6 |
chr8_85380323_85380758 | 12.10 |
Mylk3 |
myosin light chain kinase 3 |
438 |
0.77 |
chr5_113972858_113973141 | 12.09 |
Ssh1 |
slingshot protein phosphatase 1 |
6243 |
0.14 |
chr6_94390409_94390819 | 12.05 |
Gm7825 |
predicted gene 7825 |
27215 |
0.17 |
chr2_163539583_163539873 | 12.04 |
Hnf4aos |
hepatic nuclear factor 4 alpha, opposite strand |
1964 |
0.23 |
chr10_26920587_26920754 | 12.01 |
Gm48084 |
predicted gene, 48084 |
29070 |
0.17 |
chr7_143419824_143420081 | 11.97 |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C (P57) |
39359 |
0.09 |
chr12_80035037_80035218 | 11.97 |
Gm36660 |
predicted gene, 36660 |
46307 |
0.1 |
chr11_32285702_32285899 | 11.97 |
Hbq1b |
hemoglobin, theta 1B |
1165 |
0.29 |
chr6_100301817_100301974 | 11.96 |
Rybp |
RING1 and YY1 binding protein |
14410 |
0.18 |
chr3_28697845_28698003 | 11.95 |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
21 |
0.98 |
chr3_95662427_95662585 | 11.95 |
Mcl1 |
myeloid cell leukemia sequence 1 |
3649 |
0.12 |
chr19_14259408_14259559 | 11.92 |
Gm26993 |
predicted gene, 26993 |
241112 |
0.02 |
chr5_134915067_134915267 | 11.87 |
Cldn13 |
claudin 13 |
359 |
0.72 |
chr5_8873578_8873746 | 11.87 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
20055 |
0.13 |
chr18_50133862_50134181 | 11.86 |
Cd63-ps |
CD63 antigen, pseudogene |
705 |
0.67 |
chr6_88071301_88071506 | 11.83 |
Rpn1 |
ribophorin I |
13079 |
0.12 |
chr15_85771762_85772137 | 11.75 |
Ppara |
peroxisome proliferator activated receptor alpha |
265 |
0.89 |
chr6_137144827_137145296 | 11.74 |
4930480K02Rik |
RIKEN cDNA 4930480K02 gene |
1868 |
0.36 |
chr4_47294264_47294645 | 11.70 |
Col15a1 |
collagen, type XV, alpha 1 |
6167 |
0.24 |
chr13_100201785_100201950 | 11.68 |
Naip2 |
NLR family, apoptosis inhibitory protein 2 |
94 |
0.96 |
chr6_57767219_57767399 | 11.67 |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
57331 |
0.07 |
chr2_3770407_3770676 | 11.66 |
Fam107b |
family with sequence similarity 107, member B |
167 |
0.95 |
chr17_87317263_87317576 | 11.66 |
Ttc7 |
tetratricopeptide repeat domain 7 |
5649 |
0.16 |
chr5_53078471_53078628 | 11.65 |
Slc34a2 |
solute carrier family 34 (sodium phosphate), member 2 |
29196 |
0.14 |
chr12_105757874_105758401 | 11.65 |
Ak7 |
adenylate kinase 7 |
12862 |
0.17 |
chr13_25094519_25094670 | 11.64 |
Dcdc2a |
doublecortin domain containing 2a |
1753 |
0.37 |
chr6_87790818_87791085 | 11.63 |
Rab43 |
RAB43, member RAS oncogene family |
876 |
0.34 |
chr9_65191745_65191959 | 11.59 |
Parp16 |
poly (ADP-ribose) polymerase family, member 16 |
3501 |
0.15 |
chr14_118980430_118980585 | 11.59 |
Gm49768 |
predicted gene, 49768 |
3253 |
0.23 |
chr8_46404279_46404464 | 11.58 |
Gm45253 |
predicted gene 45253 |
18483 |
0.13 |
chr14_14351950_14353283 | 11.56 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr11_35732476_35732633 | 11.55 |
Pank3 |
pantothenate kinase 3 |
36930 |
0.14 |
chr3_124935266_124935435 | 11.55 |
Gm42825 |
predicted gene 42825 |
95841 |
0.08 |
chr14_121471597_121471816 | 11.51 |
Gm33299 |
predicted gene, 33299 |
15944 |
0.16 |
chr8_114130959_114131147 | 11.50 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
2504 |
0.4 |
chr11_117204633_117204995 | 11.48 |
Septin9 |
septin 9 |
5153 |
0.19 |
chr7_25402788_25402965 | 11.48 |
Lipe |
lipase, hormone sensitive |
4166 |
0.11 |
chr19_43986061_43986390 | 11.46 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
331 |
0.86 |
chr9_5286578_5286831 | 11.45 |
Casp1 |
caspase 1 |
11804 |
0.22 |
chr17_5610269_5610433 | 11.45 |
Zdhhc14 |
zinc finger, DHHC domain containing 14 |
117794 |
0.05 |
chr13_23739207_23740153 | 11.44 |
H1f2 |
H1.2 linker histone, cluster member |
872 |
0.22 |
chr14_25508747_25509095 | 11.43 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
6266 |
0.16 |
chr1_75010337_75010488 | 11.43 |
Nhej1 |
non-homologous end joining factor 1 |
36227 |
0.1 |
chr6_127321540_127321865 | 11.41 |
Gm43636 |
predicted gene 43636 |
3361 |
0.16 |
chr11_54249024_54249175 | 11.37 |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
568 |
0.6 |
chr12_101876563_101876723 | 11.37 |
Trip11 |
thyroid hormone receptor interactor 11 |
6964 |
0.15 |
chr13_41236454_41236619 | 11.32 |
Gm32063 |
predicted gene, 32063 |
191 |
0.89 |
chr2_3623586_3623819 | 11.25 |
Fam107b |
family with sequence similarity 107, member B |
9944 |
0.17 |
chr8_117695750_117696027 | 11.25 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
6016 |
0.14 |
chr7_127672339_127672529 | 11.24 |
Gm44760 |
predicted gene 44760 |
14200 |
0.08 |
chr8_94734148_94734373 | 11.21 |
Ccl22 |
chemokine (C-C motif) ligand 22 |
11330 |
0.12 |
chr1_155064106_155064532 | 11.15 |
Gm29282 |
predicted gene 29282 |
7140 |
0.16 |
chr12_32123672_32123838 | 11.14 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
53 |
0.98 |
chr19_4836167_4836318 | 11.13 |
Ccs |
copper chaperone for superoxide dismutase |
2977 |
0.1 |
chr4_63154154_63154364 | 11.12 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
86 |
0.97 |
chr1_75124388_75124807 | 11.06 |
Nhej1 |
non-homologous end joining factor 1 |
603 |
0.55 |
chr5_106705212_106705518 | 11.04 |
Zfp644 |
zinc finger protein 644 |
8078 |
0.14 |
chr11_75948882_75949196 | 11.04 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
10610 |
0.2 |
chr6_73232363_73232587 | 11.00 |
Gm40377 |
predicted gene, 40377 |
9425 |
0.17 |
chrX_36824443_36824594 | 10.98 |
Gm14549 |
predicted gene 14549 |
9747 |
0.12 |
chr14_41160837_41161034 | 10.96 |
Mbl1 |
mannose-binding lectin (protein A) 1 |
9434 |
0.11 |
chr15_81892328_81892647 | 10.96 |
Aco2 |
aconitase 2, mitochondrial |
2819 |
0.13 |
chr9_104070966_104071177 | 10.95 |
Acad11 |
acyl-Coenzyme A dehydrogenase family, member 11 |
7338 |
0.1 |
chr15_78571727_78571930 | 10.84 |
Rac2 |
Rac family small GTPase 2 |
953 |
0.39 |
chr11_19941233_19941710 | 10.84 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
13099 |
0.26 |
chr8_126774862_126775184 | 10.83 |
Gm45805 |
predicted gene 45805 |
16689 |
0.22 |
chr19_59366830_59367123 | 10.82 |
Pdzd8 |
PDZ domain containing 8 |
21196 |
0.13 |
chr1_168287679_168288893 | 10.79 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 8.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
7.9 | 23.8 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
7.8 | 31.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
7.2 | 21.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
6.9 | 34.3 | GO:0046618 | drug export(GO:0046618) |
6.4 | 19.2 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
5.9 | 17.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
5.5 | 16.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
5.4 | 10.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
4.9 | 14.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
4.7 | 23.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
4.7 | 18.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
4.7 | 4.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
4.6 | 18.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
4.4 | 13.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.4 | 22.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
4.1 | 16.4 | GO:0008228 | opsonization(GO:0008228) |
4.0 | 15.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.9 | 11.7 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
3.7 | 22.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
3.7 | 3.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
3.6 | 10.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
3.6 | 17.8 | GO:0070627 | ferrous iron import(GO:0070627) |
3.5 | 14.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
3.5 | 7.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
3.4 | 17.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
3.4 | 31.0 | GO:0070269 | pyroptosis(GO:0070269) |
3.4 | 10.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
3.4 | 13.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
3.4 | 10.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
3.3 | 10.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.3 | 10.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.3 | 9.9 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.3 | 6.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.2 | 19.4 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
3.2 | 9.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.2 | 6.4 | GO:0045472 | response to ether(GO:0045472) |
3.1 | 9.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
3.1 | 18.3 | GO:0015871 | choline transport(GO:0015871) |
3.0 | 9.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.0 | 3.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
3.0 | 9.0 | GO:0036394 | amylase secretion(GO:0036394) |
3.0 | 9.0 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
3.0 | 6.0 | GO:0032439 | endosome localization(GO:0032439) |
3.0 | 17.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.9 | 8.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.9 | 8.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.9 | 5.8 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.9 | 8.6 | GO:0019532 | oxalate transport(GO:0019532) |
2.9 | 5.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.9 | 8.6 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.8 | 11.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.8 | 31.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
2.8 | 16.8 | GO:0048069 | eye pigmentation(GO:0048069) |
2.8 | 8.4 | GO:0008050 | female courtship behavior(GO:0008050) |
2.8 | 16.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
2.8 | 8.3 | GO:0003032 | detection of oxygen(GO:0003032) |
2.7 | 16.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.7 | 10.9 | GO:1904673 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
2.7 | 8.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.7 | 8.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.7 | 10.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
2.7 | 15.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
2.7 | 8.0 | GO:1902896 | terminal web assembly(GO:1902896) |
2.6 | 13.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.6 | 20.9 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
2.6 | 2.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.6 | 2.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.5 | 5.1 | GO:0036166 | phenotypic switching(GO:0036166) |
2.5 | 12.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.5 | 20.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
2.5 | 7.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.5 | 10.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.5 | 10.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.5 | 7.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.5 | 7.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.5 | 2.5 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
2.5 | 7.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
2.5 | 2.5 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
2.4 | 9.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.4 | 7.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.4 | 9.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.4 | 2.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.4 | 9.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.4 | 4.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.3 | 4.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.3 | 6.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
2.3 | 6.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.3 | 2.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
2.3 | 6.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
2.3 | 6.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.3 | 9.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.3 | 9.1 | GO:0003383 | apical constriction(GO:0003383) |
2.3 | 4.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
2.2 | 2.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
2.2 | 6.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.2 | 8.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.2 | 8.9 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
2.2 | 6.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
2.2 | 11.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
2.2 | 6.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
2.2 | 2.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.2 | 6.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
2.1 | 8.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
2.1 | 21.5 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
2.1 | 4.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.1 | 25.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.1 | 6.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.1 | 4.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
2.1 | 10.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
2.1 | 6.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.1 | 25.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.1 | 8.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.1 | 10.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.1 | 8.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
2.1 | 6.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
2.0 | 2.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
2.0 | 2.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
2.0 | 8.1 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
2.0 | 12.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.0 | 6.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.0 | 4.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
2.0 | 5.9 | GO:0048143 | astrocyte activation(GO:0048143) |
2.0 | 5.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.9 | 5.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.9 | 9.6 | GO:0015879 | carnitine transport(GO:0015879) |
1.9 | 5.8 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.9 | 30.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
1.9 | 1.9 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.9 | 7.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.9 | 7.6 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
1.9 | 3.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.9 | 5.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 11.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.9 | 5.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.9 | 1.9 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.8 | 7.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.8 | 1.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.8 | 3.7 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.8 | 3.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.8 | 1.8 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.8 | 9.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.8 | 1.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.8 | 1.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.8 | 7.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.8 | 44.8 | GO:0048821 | erythrocyte development(GO:0048821) |
1.8 | 16.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.8 | 1.8 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.8 | 3.6 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.7 | 3.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.7 | 14.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.7 | 1.7 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.7 | 3.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.7 | 12.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.7 | 3.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.7 | 8.7 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
1.7 | 6.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.7 | 13.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.7 | 8.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.7 | 6.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.7 | 6.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.7 | 6.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.7 | 20.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.7 | 30.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
1.7 | 6.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.7 | 13.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.6 | 26.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
1.6 | 4.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.6 | 14.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.6 | 4.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.6 | 3.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.6 | 8.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.6 | 11.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.6 | 3.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.6 | 4.8 | GO:0042737 | drug catabolic process(GO:0042737) |
1.6 | 4.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.6 | 8.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.6 | 6.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.6 | 1.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.6 | 4.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.6 | 7.9 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.6 | 6.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.6 | 1.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.6 | 3.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.6 | 4.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.6 | 15.5 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.6 | 1.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.6 | 6.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.5 | 10.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.5 | 7.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.5 | 7.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.5 | 1.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
1.5 | 4.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.5 | 6.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.5 | 3.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.5 | 4.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.5 | 3.0 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.5 | 6.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.5 | 4.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.5 | 1.5 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
1.5 | 4.5 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
1.5 | 1.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.5 | 8.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.5 | 14.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
1.5 | 4.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.5 | 2.9 | GO:0006868 | glutamine transport(GO:0006868) |
1.5 | 11.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 4.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.5 | 2.9 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.5 | 4.4 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.4 | 7.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.4 | 5.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.4 | 8.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.4 | 5.7 | GO:0015793 | glycerol transport(GO:0015793) |
1.4 | 7.1 | GO:1904970 | brush border assembly(GO:1904970) |
1.4 | 4.2 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
1.4 | 4.2 | GO:0000087 | mitotic M phase(GO:0000087) |
1.4 | 5.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.4 | 4.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.4 | 2.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.4 | 12.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
1.4 | 4.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.4 | 29.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.4 | 7.0 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.4 | 4.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.4 | 5.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
1.4 | 4.1 | GO:0030242 | pexophagy(GO:0030242) |
1.4 | 2.7 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.4 | 4.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 17.7 | GO:0050779 | RNA destabilization(GO:0050779) |
1.4 | 5.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.4 | 10.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.4 | 12.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.4 | 1.4 | GO:0061724 | lipophagy(GO:0061724) |
1.4 | 10.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.3 | 13.5 | GO:0034063 | stress granule assembly(GO:0034063) |
1.3 | 6.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.3 | 8.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.3 | 5.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.3 | 4.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.3 | 5.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.3 | 4.0 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.3 | 6.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.3 | 4.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.3 | 5.3 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.3 | 4.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.3 | 1.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.3 | 9.2 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
1.3 | 6.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.3 | 11.8 | GO:0070254 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
1.3 | 2.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.3 | 3.9 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
1.3 | 3.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.3 | 1.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.3 | 3.9 | GO:0006116 | NADH oxidation(GO:0006116) |
1.3 | 2.6 | GO:0070268 | cornification(GO:0070268) |
1.3 | 2.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.3 | 2.6 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
1.3 | 2.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.3 | 3.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.3 | 3.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.3 | 2.5 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.3 | 1.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.3 | 2.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 10.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.2 | 6.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.2 | 3.7 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.2 | 6.2 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.2 | 3.7 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.2 | 8.7 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.2 | 3.7 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.2 | 4.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.2 | 1.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.2 | 4.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.2 | 2.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.2 | 7.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.2 | 8.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.2 | 2.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.2 | 8.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
1.2 | 4.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.2 | 7.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.2 | 3.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.2 | 5.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.2 | 5.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.2 | 15.1 | GO:0045116 | protein neddylation(GO:0045116) |
1.2 | 5.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.2 | 7.0 | GO:0060242 | contact inhibition(GO:0060242) |
1.2 | 13.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.2 | 1.2 | GO:0002159 | desmosome assembly(GO:0002159) |
1.2 | 4.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.2 | 2.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.2 | 1.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.2 | 10.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.2 | 3.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.2 | 1.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.1 | 3.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.1 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.1 | 2.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.1 | 3.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.1 | 2.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.1 | 3.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.1 | 3.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.1 | 2.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.1 | 2.3 | GO:0061511 | centriole elongation(GO:0061511) |
1.1 | 7.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.1 | 3.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.1 | 3.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.1 | 12.4 | GO:0030575 | nuclear body organization(GO:0030575) |
1.1 | 2.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.1 | 2.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.1 | 6.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.1 | 1.1 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
1.1 | 3.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.1 | 1.1 | GO:0032898 | neurotrophin production(GO:0032898) |
1.1 | 2.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.1 | 6.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.1 | 12.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.1 | 4.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.1 | 5.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.1 | 3.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.1 | 3.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.1 | 6.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
1.1 | 1.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.1 | 2.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.1 | 2.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.1 | 4.3 | GO:0072553 | terminal button organization(GO:0072553) |
1.1 | 7.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.1 | 5.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.1 | 8.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.1 | 4.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.1 | 3.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
1.1 | 9.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.1 | 5.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.1 | 5.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.1 | 5.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.1 | 1.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.1 | 1.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
1.1 | 9.6 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.1 | 3.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.1 | 1.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.1 | 1.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.1 | 3.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.1 | 3.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.1 | 6.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.0 | 4.2 | GO:0051031 | tRNA transport(GO:0051031) |
1.0 | 6.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.0 | 18.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.0 | 2.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.0 | 1.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.0 | 2.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
1.0 | 3.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.0 | 3.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.0 | 3.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.0 | 7.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.0 | 3.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.0 | 3.1 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.0 | 2.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.0 | 4.1 | GO:0060613 | fat pad development(GO:0060613) |
1.0 | 11.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.0 | 1.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.0 | 1.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.0 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.0 | 4.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.0 | 27.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.0 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.0 | 2.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.0 | 6.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.0 | 5.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.0 | 14.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.0 | 3.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.0 | 2.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.0 | 9.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.0 | 2.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.0 | 2.0 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
1.0 | 3.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.0 | 4.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 3.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.0 | 2.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 6.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
1.0 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.0 | 3.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 4.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.0 | 4.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.0 | 4.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.0 | 1.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.0 | 6.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.0 | 5.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.0 | 3.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.0 | 7.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.0 | 5.9 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
1.0 | 2.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 6.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.0 | 2.9 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.0 | 9.7 | GO:0018904 | ether metabolic process(GO:0018904) |
1.0 | 2.9 | GO:0015888 | thiamine transport(GO:0015888) |
1.0 | 13.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.0 | 7.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.0 | 4.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.0 | 1.0 | GO:0010226 | response to lithium ion(GO:0010226) |
1.0 | 3.9 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
1.0 | 1.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.0 | 4.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.0 | 1.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.0 | 1.9 | GO:0033058 | directional locomotion(GO:0033058) |
1.0 | 1.0 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
1.0 | 3.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.0 | 2.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 5.7 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
1.0 | 5.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.9 | 2.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.9 | 2.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.9 | 1.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.9 | 2.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.9 | 3.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.9 | 0.9 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.9 | 2.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.9 | 2.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.9 | 2.8 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.9 | 12.2 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.9 | 4.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.9 | 6.6 | GO:0007343 | egg activation(GO:0007343) |
0.9 | 3.7 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.9 | 10.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.9 | 5.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.9 | 1.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) cellular response to arsenic-containing substance(GO:0071243) |
0.9 | 5.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.9 | 2.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.9 | 1.8 | GO:0050904 | diapedesis(GO:0050904) |
0.9 | 5.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.9 | 2.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 11.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.9 | 3.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.9 | 1.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.9 | 3.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.9 | 3.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.9 | 2.7 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.9 | 11.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.9 | 3.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.9 | 2.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.9 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 6.3 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.9 | 3.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.9 | 0.9 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.9 | 1.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.9 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.9 | 2.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.9 | 3.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.9 | 2.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.9 | 7.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.9 | 2.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.9 | 2.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.9 | 2.7 | GO:0015705 | iodide transport(GO:0015705) |
0.9 | 3.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.9 | 8.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.9 | 2.7 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.9 | 2.7 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.9 | 2.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.9 | 4.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.9 | 1.8 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.9 | 2.6 | GO:0009838 | abscission(GO:0009838) |
0.9 | 13.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.9 | 6.1 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.9 | 2.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.9 | 1.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.9 | 16.5 | GO:0014823 | response to activity(GO:0014823) |
0.9 | 4.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.9 | 1.7 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.9 | 0.9 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.9 | 0.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.9 | 9.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.9 | 3.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.9 | 5.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.9 | 10.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.8 | 11.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.8 | 3.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.8 | 2.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.8 | 6.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.8 | 1.7 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 1.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.8 | 1.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.8 | 0.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.8 | 0.8 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.8 | 5.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.8 | 2.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.8 | 4.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 2.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 9.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.8 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 6.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.8 | 2.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.8 | 2.5 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of ceramide biosynthetic process(GO:2000303) |
0.8 | 9.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.8 | 1.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.8 | 3.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.8 | 1.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 0.8 | GO:0033363 | secretory granule organization(GO:0033363) |
0.8 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 0.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.8 | 2.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 5.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.8 | 1.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.8 | 3.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.8 | 0.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.8 | 0.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.8 | 0.8 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.8 | 8.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.8 | 6.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.8 | 0.8 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.8 | 3.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.8 | 4.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.8 | 3.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.8 | 3.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.8 | 7.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.8 | 15.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.8 | 4.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.8 | 13.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.8 | 3.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.8 | 1.6 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.8 | 4.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.8 | 1.6 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.8 | 1.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.8 | 5.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.8 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.8 | 0.8 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.8 | 2.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.8 | 4.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.8 | 1.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.8 | 2.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.8 | 4.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.8 | 8.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.8 | 0.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.8 | 1.6 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.8 | 1.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.8 | 0.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.8 | 3.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.8 | 2.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 2.3 | GO:0051775 | response to redox state(GO:0051775) |
0.8 | 0.8 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.8 | 5.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.8 | 0.8 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.8 | 0.8 | GO:1902337 | regulation of apoptotic process involved in morphogenesis(GO:1902337) |
0.8 | 1.5 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.8 | 0.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.8 | 3.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.8 | 6.9 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.8 | 0.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.8 | 1.5 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.8 | 3.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.8 | 13.0 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.8 | 0.8 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.8 | 1.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.8 | 5.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 9.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.8 | 2.3 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.8 | 4.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.8 | 12.8 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.8 | 1.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.7 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 3.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.7 | 0.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 3.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 3.7 | GO:0000237 | leptotene(GO:0000237) |
0.7 | 5.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 0.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.7 | 2.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.7 | 3.7 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.7 | 1.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.7 | 8.8 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.7 | 2.9 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.7 | 3.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.7 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.7 | 2.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.7 | 1.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.7 | 8.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.7 | 1.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 0.7 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.7 | 2.2 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.7 | 1.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.7 | 0.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.7 | 0.7 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.7 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.7 | 6.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.7 | 2.8 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.7 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 2.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 4.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.7 | 6.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.7 | 2.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 0.7 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.7 | 2.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.7 | 2.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.7 | 5.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.7 | 1.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.7 | 14.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.7 | 2.8 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.7 | 5.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.7 | 1.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.7 | 11.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.7 | 11.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.7 | 4.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.7 | 1.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.7 | 2.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.7 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.7 | 4.8 | GO:0009650 | UV protection(GO:0009650) |
0.7 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 3.4 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.7 | 2.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 12.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.7 | 2.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.7 | 4.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 2.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.7 | 0.7 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.7 | 6.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.7 | 4.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.7 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 5.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.7 | 2.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.7 | 0.7 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.7 | 0.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 0.7 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.7 | 1.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.7 | 10.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.7 | 1.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 20.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.7 | 2.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.7 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.7 | 10.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.7 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.7 | 2.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 4.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 11.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.7 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.7 | 1.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.7 | 1.3 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.7 | 3.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.7 | 2.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.7 | 6.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.7 | 0.7 | GO:1901382 | transforming growth factor beta receptor complex assembly(GO:0007181) chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.7 | 5.9 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.7 | 2.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 0.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.7 | 0.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.7 | 3.9 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.6 | 2.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.6 | 1.9 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 5.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.6 | 1.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.6 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 2.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 2.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 0.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 0.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.6 | 1.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.6 | 1.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.6 | 1.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.6 | 5.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.6 | 6.9 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.6 | 2.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 1.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.6 | 0.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.6 | 2.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.6 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.6 | 1.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.6 | 1.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 0.6 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.6 | 4.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.6 | 1.9 | GO:0015744 | succinate transport(GO:0015744) |
0.6 | 2.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 3.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.6 | 1.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 0.6 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.6 | 0.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 0.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.6 | 2.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.6 | 1.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.6 | 0.6 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.6 | 0.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 1.2 | GO:0046629 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
0.6 | 1.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.6 | 1.8 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.6 | 7.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.6 | 0.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.6 | 0.6 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.6 | 2.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 0.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.6 | 1.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.6 | 1.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.6 | 0.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 1.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.6 | 9.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.6 | 1.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.6 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.6 | 0.6 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.6 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.6 | 1.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.6 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.6 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.6 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 1.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.6 | 1.1 | GO:0060926 | atrioventricular node development(GO:0003162) cardiac pacemaker cell development(GO:0060926) |
0.6 | 1.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 13.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 4.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.6 | 0.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.6 | 2.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.6 | 0.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.6 | 2.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 0.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.6 | 0.6 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.6 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.6 | 1.7 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.6 | 3.9 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.6 | 0.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.6 | 1.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.6 | 0.6 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.6 | 2.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 0.6 | GO:0001705 | ectoderm formation(GO:0001705) |
0.6 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 3.3 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 1.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.6 | 1.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.5 | 2.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 3.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 3.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 3.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.5 | 1.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.5 | 0.5 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.5 | 6.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 1.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.5 | 0.5 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.5 | 1.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.5 | 0.5 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.5 | 0.5 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.5 | 3.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.5 | 1.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.5 | 7.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.5 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 2.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 1.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.5 | 2.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.5 | 2.7 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.5 | 1.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.5 | 3.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.5 | 0.5 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.5 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.5 | 11.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 3.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.5 | 1.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.5 | 4.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.5 | 3.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 3.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.5 | 1.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.5 | 8.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 0.5 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.5 | 1.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.5 | 5.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.5 | 2.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.5 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 1.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 0.5 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.5 | 1.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.5 | 3.6 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.5 | 9.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.5 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 1.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 10.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.5 | 0.5 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.5 | 2.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 1.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 1.0 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 1.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 0.5 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.5 | 1.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 2.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 1.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 1.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 1.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.5 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.5 | 1.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 2.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 2.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 12.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 1.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 1.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 0.5 | GO:0090656 | t-circle formation(GO:0090656) regulation of t-circle formation(GO:1904429) |
0.5 | 1.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 2.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.5 | 1.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 4.9 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.5 | 20.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.5 | 3.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 1.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 1.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 1.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.5 | 1.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.5 | 1.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.5 | 6.7 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.5 | 1.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.5 | 1.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.5 | 2.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.5 | 1.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.5 | 1.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 3.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.5 | 0.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.5 | 6.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.5 | 1.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.5 | 6.6 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.5 | 1.9 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.5 | 2.3 | GO:0060068 | vagina development(GO:0060068) |
0.5 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 3.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 0.9 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 5.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 7.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.5 | 1.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 2.8 | GO:0015893 | drug transport(GO:0015893) |
0.5 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.5 | 13.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.5 | 0.9 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.5 | 0.5 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.5 | 0.9 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.5 | 1.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.5 | 0.9 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.5 | 1.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.5 | 1.8 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.5 | 4.1 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.5 | 3.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.5 | 1.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 2.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 1.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 0.9 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.5 | 1.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.5 | 8.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.5 | 1.8 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.5 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 1.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 0.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 6.3 | GO:0019915 | lipid storage(GO:0019915) |
0.5 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 2.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 2.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 2.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 0.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 3.1 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 2.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.4 | 2.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.4 | 12.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 7.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.4 | 0.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 3.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) quinone biosynthetic process(GO:1901663) |
0.4 | 1.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 0.9 | GO:0006848 | pyruvate transport(GO:0006848) |
0.4 | 4.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 0.9 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.4 | 3.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 2.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 1.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 1.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 0.9 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 1.7 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.4 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 3.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 1.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 0.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.4 | 0.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 0.4 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.4 | 1.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 2.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 4.6 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.4 | 3.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.4 | 5.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 1.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 2.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.4 | 0.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.4 | 0.8 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 1.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.4 | 2.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 1.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.4 | 0.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.4 | 0.4 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 | 1.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 0.8 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 1.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 2.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 1.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.4 | 2.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 0.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 2.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 2.8 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.4 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 2.0 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 2.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 8.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.4 | 3.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.4 | 3.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.4 | 0.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.4 | 1.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.4 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 2.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.4 | 2.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 0.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 2.8 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.4 | 3.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 0.8 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 0.4 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.4 | 4.3 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 0.4 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.4 | 2.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 1.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 1.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 3.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 0.8 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.4 | 1.6 | GO:0072678 | T cell migration(GO:0072678) |
0.4 | 0.4 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.4 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 1.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 1.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 0.4 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.4 | 9.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.4 | 1.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 3.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.4 | 3.1 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.4 | 3.8 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.4 | 9.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 0.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 0.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 1.5 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.4 | 0.8 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.4 | 1.9 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.4 | 0.8 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.4 | 1.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 4.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.4 | 1.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.4 | 3.8 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.4 | 0.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.4 | 6.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.4 | 1.1 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 6.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.4 | 1.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 5.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 3.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.4 | 0.4 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.4 | 1.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 1.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 0.4 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.4 | 1.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.4 | 0.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 0.7 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.4 | 0.4 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 0.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.4 | 1.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 10.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 2.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.4 | 0.7 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.4 | 0.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 4.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 0.7 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 1.5 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.4 | 0.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.4 | 0.7 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.4 | 0.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.4 | 1.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 3.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.4 | 1.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 1.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 2.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 2.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 2.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.4 | 0.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.4 | 1.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.4 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 10.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 5.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 2.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 2.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 1.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.3 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 0.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 1.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 2.4 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.3 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.3 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.3 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 1.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 1.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 3.4 | GO:0032355 | response to estradiol(GO:0032355) |
0.3 | 1.0 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 1.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.3 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.3 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.7 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.3 | 2.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 2.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 1.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 0.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.3 | 0.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) negative regulation of RNA catabolic process(GO:1902369) |
0.3 | 3.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 2.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 2.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 1.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 2.6 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.3 | 1.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 7.1 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.3 | 6.8 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.3 | 1.3 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.3 | 0.3 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.3 | 0.3 | GO:0010743 | regulation of macrophage derived foam cell differentiation(GO:0010743) |
0.3 | 0.6 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.3 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 1.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 0.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.3 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 1.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 0.6 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 2.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.3 | GO:0034311 | diol metabolic process(GO:0034311) |
0.3 | 11.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.3 | 0.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 5.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 0.9 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.3 | 3.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 1.9 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 1.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 23.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.3 | 0.9 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.3 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.9 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.3 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 2.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 0.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 5.2 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.3 | 9.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 1.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 1.8 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.3 | 1.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 5.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 0.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 0.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 0.6 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 1.2 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 1.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 0.6 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.3 | 0.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 2.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 1.5 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 1.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 4.4 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 0.9 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.3 | 0.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.9 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 0.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 2.0 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.3 | 3.8 | GO:0070542 | response to fatty acid(GO:0070542) |
0.3 | 0.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 1.4 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.6 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 1.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.3 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 0.9 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.3 | 7.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.3 | 13.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.3 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 0.8 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.3 | 3.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 0.3 | GO:0071724 | response to bacterial lipoprotein(GO:0032493) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.3 | 1.1 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.3 | 0.6 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.3 | 0.6 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.3 | 1.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 0.6 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 0.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 2.8 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.3 | 0.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 0.3 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.3 | 3.3 | GO:0032608 | interferon-beta production(GO:0032608) |
0.3 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 0.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.3 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.3 | 0.5 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 1.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 1.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.3 | 0.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 0.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 0.5 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.3 | 4.0 | GO:0014904 | myotube cell development(GO:0014904) |
0.3 | 0.3 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.3 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 4.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 1.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 1.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.3 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 6.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 4.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.3 | 5.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 1.3 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.3 | GO:0034204 | lipid translocation(GO:0034204) |
0.3 | 0.5 | GO:0071397 | response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
0.3 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 1.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 1.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 0.8 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 4.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 0.5 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.3 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.8 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.3 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 0.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.7 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 2.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 0.7 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.2 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.2 | 0.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.7 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 3.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.7 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.7 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.2 | 0.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 3.1 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.7 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.7 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.2 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.9 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 | 1.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 2.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 1.8 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.7 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 2.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.9 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.2 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 0.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 2.2 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.9 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 3.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.9 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 0.4 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 1.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.2 | 2.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.9 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 1.9 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 2.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.6 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 2.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 1.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 1.0 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.8 | GO:0042116 | macrophage activation(GO:0042116) |
0.2 | 7.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 1.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.2 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 6.7 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 5.3 | GO:0035036 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.2 | 1.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.0 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.2 | 0.6 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.2 | 0.2 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.2 | 1.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.4 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.2 | 0.6 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.7 | GO:0051180 | vitamin transport(GO:0051180) |
0.2 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.2 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 17.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.2 | 2.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 0.2 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 17.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.2 | 1.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 0.5 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 1.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 1.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.5 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 0.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.2 | 0.5 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.2 | 1.4 | GO:0097369 | sodium ion import(GO:0097369) |
0.2 | 0.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.3 | GO:0071467 | cellular response to pH(GO:0071467) |
0.2 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.2 | 1.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.3 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.2 | 1.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 0.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.5 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.2 | 0.2 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.2 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) viral entry into host cell(GO:0046718) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.2 | 1.3 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.2 | 0.2 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.2 | 0.3 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.2 | 1.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.8 | GO:0030104 | water homeostasis(GO:0030104) |
0.2 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.2 | 1.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.6 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.2 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.3 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.2 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.5 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.6 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 6.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 2.4 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0002676 | chronic inflammatory response(GO:0002544) regulation of chronic inflammatory response(GO:0002676) |
0.1 | 0.4 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 1.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 2.0 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.6 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 1.0 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 4.2 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 14.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.8 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.1 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 8.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.8 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 4.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 0.3 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 0.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 1.0 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.1 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.6 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 1.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 1.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.6 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 0.5 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:0009084 | proline biosynthetic process(GO:0006561) glutamine family amino acid biosynthetic process(GO:0009084) |
0.1 | 0.1 | GO:0034381 | plasma lipoprotein particle clearance(GO:0034381) |
0.1 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.6 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.1 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 3.4 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 1.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 3.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.8 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.1 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 1.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.2 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 1.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.5 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:0097468 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 1.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.1 | 0.2 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.3 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 2.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.1 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 2.7 | GO:0001890 | placenta development(GO:0001890) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 3.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 17.1 | GO:0048232 | male gamete generation(GO:0048232) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:0060439 | trachea morphogenesis(GO:0060439) |
0.1 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.1 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 5.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.1 | GO:0016321 | male meiosis chromosome segregation(GO:0007060) female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.0 | 0.1 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 5.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.0 | GO:0002702 | positive regulation of production of molecular mediator of immune response(GO:0002702) |
0.0 | 0.0 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 1.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.9 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.0 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0090185 | negative regulation of kidney development(GO:0090185) |
0.0 | 0.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.1 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.0 | 0.0 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.0 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.0 | 0.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0050704 | regulation of interleukin-1 secretion(GO:0050704) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 27.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
6.2 | 30.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
5.1 | 30.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
4.2 | 42.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
4.1 | 20.5 | GO:0031983 | vesicle lumen(GO:0031983) |
3.5 | 14.0 | GO:0033269 | internode region of axon(GO:0033269) |
3.3 | 9.8 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.7 | 8.2 | GO:1990635 | proximal dendrite(GO:1990635) |
2.7 | 53.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.6 | 7.8 | GO:0031523 | Myb complex(GO:0031523) |
2.5 | 7.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.4 | 9.7 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.4 | 21.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
2.4 | 7.1 | GO:0097443 | sorting endosome(GO:0097443) |
2.3 | 7.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.3 | 21.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
2.2 | 8.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.1 | 6.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.1 | 10.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.0 | 10.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.9 | 3.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.9 | 5.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.9 | 9.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.8 | 14.7 | GO:0045179 | apical cortex(GO:0045179) |
1.8 | 7.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.8 | 8.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.7 | 5.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.7 | 8.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.6 | 1.6 | GO:0071986 | Ragulator complex(GO:0071986) |
1.6 | 8.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.6 | 6.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.6 | 3.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.5 | 10.8 | GO:0030056 | hemidesmosome(GO:0030056) |
1.5 | 7.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.5 | 4.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.5 | 6.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.5 | 4.5 | GO:0070552 | BRISC complex(GO:0070552) |
1.5 | 5.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.4 | 5.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.4 | 4.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.4 | 5.6 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.4 | 8.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.4 | 4.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.4 | 8.2 | GO:0043219 | lateral loop(GO:0043219) |
1.4 | 1.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 8.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.4 | 8.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.3 | 18.7 | GO:0031528 | microvillus membrane(GO:0031528) |
1.3 | 2.6 | GO:0097413 | Lewy body(GO:0097413) |
1.3 | 145.8 | GO:0005903 | brush border(GO:0005903) |
1.3 | 8.9 | GO:0042382 | paraspeckles(GO:0042382) |
1.3 | 2.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.3 | 6.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.3 | 1.3 | GO:1990423 | RZZ complex(GO:1990423) |
1.2 | 5.0 | GO:0042641 | actomyosin(GO:0042641) |
1.2 | 3.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.2 | 28.1 | GO:0008305 | integrin complex(GO:0008305) |
1.2 | 3.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.2 | 7.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.2 | 6.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.2 | 2.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.2 | 4.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.1 | 2.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
1.1 | 4.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.1 | 7.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 3.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 3.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 4.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.1 | 3.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.1 | 3.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.1 | 3.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.1 | 6.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 2.1 | GO:0001739 | sex chromatin(GO:0001739) |
1.1 | 10.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.0 | 3.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.0 | 7.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 8.2 | GO:0032797 | SMN complex(GO:0032797) |
1.0 | 4.1 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 2.0 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
1.0 | 42.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.0 | 3.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.0 | 3.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.0 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.0 | 7.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.0 | 14.5 | GO:0042599 | lamellar body(GO:0042599) |
1.0 | 4.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.0 | 2.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.9 | 3.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 83.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.9 | 2.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.9 | 1.9 | GO:0071203 | WASH complex(GO:0071203) |
0.9 | 2.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.9 | 19.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 0.9 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.9 | 3.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.9 | 11.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.9 | 7.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.9 | 2.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.9 | 6.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.9 | 8.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 8.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.9 | 26.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.9 | 3.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.9 | 2.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.9 | 3.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.9 | 6.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.9 | 1.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.9 | 2.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.9 | 5.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.8 | 5.1 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 9.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 13.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.8 | 3.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.8 | 2.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 2.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.8 | 1.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.8 | 4.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.8 | 2.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.8 | 3.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.8 | 4.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.8 | 4.7 | GO:0005818 | aster(GO:0005818) |
0.8 | 2.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.8 | 1.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 3.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 2.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 16.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.8 | 2.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 6.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.7 | 4.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 3.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.7 | 2.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.7 | 10.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 2.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.7 | 5.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.7 | 8.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.7 | 2.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 4.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.7 | 2.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.7 | 2.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.7 | 25.7 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 4.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.7 | 0.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 26.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 4.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.7 | 2.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.7 | 2.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.7 | 8.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.7 | 2.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.7 | 2.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.7 | 7.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 7.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 5.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 12.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.7 | 2.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 1.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.7 | 9.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.7 | 3.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.7 | 1.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 3.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.7 | 4.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.7 | 2.6 | GO:0000938 | GARP complex(GO:0000938) |
0.6 | 8.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.6 | 29.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.6 | 3.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 2.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.6 | 18.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 10.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 2.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 1.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.6 | 3.1 | GO:0005638 | lamin filament(GO:0005638) |
0.6 | 5.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.6 | 1.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 2.5 | GO:0030891 | VCB complex(GO:0030891) |
0.6 | 6.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 2.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 1.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 5.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 2.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 3.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.6 | 0.6 | GO:1903349 | omegasome membrane(GO:1903349) |
0.6 | 12.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.6 | 38.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.6 | 96.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.6 | 25.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 1.2 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 4.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 6.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 2.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 1.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.6 | 2.3 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.6 | 1.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 18.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.6 | 8.6 | GO:0000145 | exocyst(GO:0000145) |
0.6 | 18.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 4.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.6 | 28.4 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 2.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.6 | 3.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 2.8 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.6 | 68.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.6 | 3.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.5 | 4.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.6 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 3.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 9.2 | GO:0045120 | pronucleus(GO:0045120) |
0.5 | 3.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 4.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 19.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 7.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 22.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 4.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 1.0 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 7.8 | GO:0043034 | costamere(GO:0043034) |
0.5 | 3.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.5 | 1.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 1.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 2.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.5 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 3.5 | GO:0002102 | podosome(GO:0002102) |
0.5 | 1.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 15.5 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 1.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 1.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 59.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.5 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 2.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 1.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 6.8 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 1.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 90.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.5 | 26.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 1.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 4.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.5 | 2.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 4.2 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 3.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 1.8 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.5 | 0.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 2.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.4 | 1.3 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 1.3 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.4 | 2.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 3.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 1.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 19.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 3.8 | GO:0031430 | M band(GO:0031430) |
0.4 | 1.3 | GO:0002177 | manchette(GO:0002177) |
0.4 | 1.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 2.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 3.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 2.1 | GO:0033503 | HULC complex(GO:0033503) |
0.4 | 1.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 1.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 1.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 1.7 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 2.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 2.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 2.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 5.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 46.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.4 | 9.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 2.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 1.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 0.8 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 4.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 1.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 5.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 15.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 5.6 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 5.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 2.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 3.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 15.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 7.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 1.6 | GO:0035363 | histone locus body(GO:0035363) |
0.4 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 13.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.4 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 1.2 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 3.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 9.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 1.9 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.4 | 1.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 29.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.4 | 6.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.4 | 9.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 4.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 5.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 20.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 15.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 6.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 3.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 11.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.3 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 2.1 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 1.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 26.9 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 2.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 12.4 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 4.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 8.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.3 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 4.2 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 5.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 27.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.3 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 0.6 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.3 | 4.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 1.6 | GO:0001652 | granular component(GO:0001652) |
0.3 | 2.5 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 4.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 2.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 1.2 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.2 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 3.1 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 6.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.3 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 279.0 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 1.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 8.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 2.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 28.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 38.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 1.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.3 | 1.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 0.6 | GO:0000803 | sex chromosome(GO:0000803) XY body(GO:0001741) |
0.3 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.9 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 1.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.3 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 1.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 13.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 5.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 5.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 14.5 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.2 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 14.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 2.5 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 3.6 | GO:0036126 | sperm flagellum(GO:0036126) |
0.2 | 282.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 6.9 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.3 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 3.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 68.8 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 2.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 6.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 27.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 1.8 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 110.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 1.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 130.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) NatC complex(GO:0031417) |
0.2 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.3 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 2.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 3.3 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 44.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 2.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.7 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 3.0 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.1 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 13.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 31.8 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.7 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 5.6 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.3 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.6 | GO:0005773 | vacuole(GO:0005773) |
0.1 | 0.2 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 8.0 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.8 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.0 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 15.7 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 50.1 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 10.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.9 | GO:1990234 | transferase complex(GO:1990234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.4 | 28.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
7.4 | 22.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.5 | 25.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
6.2 | 24.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.9 | 23.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
5.4 | 21.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
5.3 | 26.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
4.9 | 14.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.6 | 13.8 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
4.2 | 16.8 | GO:0009374 | biotin binding(GO:0009374) |
4.1 | 12.3 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.7 | 11.0 | GO:0019862 | IgA binding(GO:0019862) |
3.5 | 10.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.5 | 3.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
3.3 | 13.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
3.3 | 3.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
3.3 | 9.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
3.2 | 9.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.2 | 9.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.1 | 15.7 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
3.1 | 9.3 | GO:0004064 | arylesterase activity(GO:0004064) |
3.0 | 15.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
3.0 | 12.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
3.0 | 15.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
3.0 | 8.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.8 | 19.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.7 | 8.2 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
2.7 | 8.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.7 | 10.9 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
2.7 | 10.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.6 | 2.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
2.6 | 7.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
2.5 | 5.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.5 | 7.5 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.5 | 10.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.5 | 4.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
2.4 | 4.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.4 | 7.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.4 | 7.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.4 | 19.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.4 | 7.1 | GO:0050692 | DBD domain binding(GO:0050692) |
2.3 | 7.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.3 | 21.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
2.3 | 11.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.3 | 25.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.3 | 13.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.3 | 6.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
2.2 | 4.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.2 | 6.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
2.2 | 2.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
2.2 | 6.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.2 | 2.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
2.1 | 6.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.1 | 6.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.1 | 12.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.1 | 10.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.1 | 14.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
2.0 | 6.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
2.0 | 4.0 | GO:0019808 | polyamine binding(GO:0019808) |
2.0 | 22.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
2.0 | 18.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
2.0 | 6.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
2.0 | 7.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
2.0 | 25.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.9 | 9.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.9 | 7.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.9 | 22.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.9 | 7.4 | GO:0015232 | heme transporter activity(GO:0015232) |
1.8 | 7.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.8 | 5.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.8 | 1.8 | GO:0002054 | nucleobase binding(GO:0002054) |
1.8 | 5.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 7.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.8 | 5.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.8 | 5.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.8 | 10.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.8 | 7.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.8 | 5.3 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
1.8 | 7.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.7 | 8.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.7 | 5.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.7 | 1.7 | GO:0034618 | arginine binding(GO:0034618) |
1.7 | 5.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.7 | 12.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.7 | 8.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.7 | 1.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.7 | 23.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.7 | 5.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.7 | 5.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.7 | 6.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.7 | 19.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.6 | 11.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.6 | 8.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.6 | 8.2 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
1.6 | 4.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.6 | 4.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.6 | 1.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.6 | 6.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.6 | 4.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.6 | 36.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.6 | 3.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.6 | 4.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.6 | 9.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.6 | 9.5 | GO:0008199 | ferric iron binding(GO:0008199) |
1.6 | 1.6 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
1.5 | 7.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.5 | 13.7 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.5 | 12.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.5 | 9.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.5 | 3.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.5 | 6.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.5 | 4.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.5 | 4.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.5 | 4.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.5 | 2.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.5 | 4.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.5 | 5.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.4 | 4.3 | GO:0000339 | RNA cap binding(GO:0000339) |
1.4 | 4.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.4 | 17.2 | GO:0044548 | S100 protein binding(GO:0044548) |
1.4 | 4.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.4 | 5.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.4 | 18.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.4 | 21.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.4 | 2.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.4 | 4.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.4 | 12.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.4 | 7.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.4 | 1.4 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.4 | 5.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.4 | 8.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.4 | 5.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.4 | 2.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.3 | 8.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.3 | 4.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.3 | 12.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.3 | 6.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.3 | 11.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.3 | 21.0 | GO:0008483 | transaminase activity(GO:0008483) |
1.3 | 6.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.3 | 2.6 | GO:0015928 | fucosidase activity(GO:0015928) |
1.3 | 3.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.3 | 22.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.3 | 10.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.3 | 1.3 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
1.3 | 3.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.3 | 3.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.3 | 17.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.3 | 3.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.3 | 3.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.3 | 1.3 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
1.3 | 8.9 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.3 | 3.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.3 | 3.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.2 | 7.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.2 | 5.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.2 | 6.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.2 | 27.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.2 | 6.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.2 | 2.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.2 | 4.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.2 | 4.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.2 | 3.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.2 | 4.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 3.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.2 | 3.6 | GO:0030984 | kininogen binding(GO:0030984) |
1.2 | 13.1 | GO:0016918 | retinal binding(GO:0016918) |
1.2 | 10.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.2 | 5.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.2 | 1.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
1.2 | 3.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.2 | 3.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.2 | 3.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.2 | 2.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.1 | 3.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.1 | 9.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.1 | 5.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.1 | 12.5 | GO:0015250 | water channel activity(GO:0015250) |
1.1 | 15.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.1 | 11.4 | GO:0051400 | BH domain binding(GO:0051400) |
1.1 | 1.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.1 | 32.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.1 | 24.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.1 | 2.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.1 | 3.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.1 | 3.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.1 | 7.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.1 | 4.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.1 | 3.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
1.1 | 3.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 3.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.1 | 16.3 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 64.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.1 | 4.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.1 | 16.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.1 | 11.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.1 | 5.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.1 | 8.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.1 | 2.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.1 | 3.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.0 | 5.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.0 | 5.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.0 | 5.2 | GO:0016936 | galactoside binding(GO:0016936) |
1.0 | 26.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.0 | 6.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.0 | 10.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.0 | 8.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.0 | 3.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.0 | 14.5 | GO:0008143 | poly(A) binding(GO:0008143) |
1.0 | 5.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 8.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 3.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 5.0 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
1.0 | 8.9 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.0 | 3.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.0 | 1.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
1.0 | 2.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.0 | 1.9 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.0 | 3.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.0 | 8.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.0 | 11.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.0 | 12.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.0 | 8.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.0 | 10.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.0 | 6.7 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.0 | 4.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.9 | 3.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.9 | 3.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.9 | 0.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.9 | 4.7 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.9 | 7.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.9 | 6.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.9 | 2.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 11.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 4.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.9 | 28.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.9 | 3.7 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.9 | 10.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.9 | 3.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.9 | 29.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.9 | 1.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.9 | 3.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.9 | 29.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.9 | 5.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 18.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 3.5 | GO:0005534 | galactose binding(GO:0005534) |
0.9 | 4.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.9 | 5.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.9 | 2.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.9 | 2.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.9 | 4.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.9 | 1.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 7.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 2.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.8 | 9.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.8 | 1.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.8 | 7.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 3.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 3.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 8.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.8 | 10.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 2.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.8 | 19.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.8 | 5.6 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.8 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.8 | 0.8 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.8 | 4.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.8 | 21.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.8 | 4.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.8 | 3.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.8 | 3.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 3.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 22.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.8 | 5.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.8 | 2.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.8 | 4.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 13.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 8.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 3.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 7.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.8 | 10.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.8 | 2.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 2.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 2.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.8 | 2.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.8 | 2.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.8 | 5.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.8 | 12.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.8 | 8.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 23.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.8 | 1.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.7 | 2.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.7 | 14.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.7 | 2.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.7 | 0.7 | GO:1901567 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.7 | 12.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.7 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 2.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 7.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 3.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.7 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.7 | 2.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.7 | 2.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.7 | 3.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 9.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.7 | 5.7 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.7 | 2.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 0.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 3.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.7 | 2.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.7 | 6.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 18.8 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.7 | 2.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.7 | 3.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.7 | 2.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.7 | 15.8 | GO:0043531 | ADP binding(GO:0043531) |
0.7 | 0.7 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.7 | 2.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 2.7 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.7 | 4.1 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 0.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.7 | 4.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 1.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.7 | 2.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.7 | 0.7 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.7 | 2.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.7 | 4.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.7 | 2.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 2.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.7 | 11.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 1.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 4.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.7 | 2.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 9.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 3.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.6 | 1.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.6 | 1.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.6 | 1.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 0.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.6 | 1.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 4.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.6 | 3.8 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.6 | 3.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.6 | 51.0 | GO:0002020 | protease binding(GO:0002020) |
0.6 | 1.9 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.6 | 3.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 6.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 15.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.6 | 1.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 5.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.6 | 1.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 6.8 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.6 | 4.9 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.6 | 4.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 1.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 4.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 62.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.6 | 2.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 2.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 4.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 1.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.6 | 21.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 4.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.6 | 40.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.6 | 6.0 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.6 | 5.9 | GO:0005536 | glucose binding(GO:0005536) |
0.6 | 1.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 1.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 4.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 1.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 1.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 3.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 11.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.6 | 1.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.6 | 3.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.6 | 5.8 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 2.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 1.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.6 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 2.9 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 1.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.6 | 17.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.6 | 1.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 2.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 2.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.6 | 1.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 2.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.6 | 5.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 5.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 3.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 6.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 13.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.6 | 18.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 2.8 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.6 | 2.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 4.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.6 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 3.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 6.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 1.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.5 | 0.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 0.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.5 | 2.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.5 | 1.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 4.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.5 | 1.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.5 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 2.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.5 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 4.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.5 | 2.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 3.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 7.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 4.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.5 | 2.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 9.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 1.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 0.5 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.5 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 2.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 4.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 7.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.5 | 1.0 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.5 | 2.5 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.5 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 2.0 | GO:0016208 | AMP binding(GO:0016208) |
0.5 | 1.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 10.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 2.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.5 | 9.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 1.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 1.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.5 | 1.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 0.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.5 | 1.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 5.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 1.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.5 | 8.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 4.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 1.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.5 | 1.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 1.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 1.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.5 | 2.4 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.5 | 1.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 7.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 10.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 5.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.5 | 2.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 6.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.5 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 0.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 1.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 1.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 1.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 3.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.5 | 5.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.5 | 10.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.5 | 1.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 3.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 2.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 21.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.4 | 0.9 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 4.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 5.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 4.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 1.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 2.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 2.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 6.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.4 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 9.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 3.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 0.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 1.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 3.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 1.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 1.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 6.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.4 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 2.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 9.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 0.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 1.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 1.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 5.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 4.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 3.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.4 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 2.4 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 2.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 4.0 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 4.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 12.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.4 | 1.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 3.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 2.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 0.4 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.4 | 1.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.4 | 4.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 1.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 10.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 6.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 19.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.4 | 1.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 38.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 5.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 1.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 6.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.1 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 2.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.4 | 3.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 2.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 6.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 11.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.4 | 3.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 26.4 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.4 | 1.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.4 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.4 | 1.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 2.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 3.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.4 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 0.7 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 4.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 2.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 0.4 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 2.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 2.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 1.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 9.8 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 1.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 1.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 4.7 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 7.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 2.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 0.3 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 3.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 4.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.3 | 10.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 8.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 1.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.3 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 6.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 4.2 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.3 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 2.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 0.9 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.3 | 0.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 17.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.3 | 5.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 50.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 4.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 0.9 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.3 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 6.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 3.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 2.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 0.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 12.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 4.7 | GO:0051020 | GTPase binding(GO:0051020) |
0.3 | 12.5 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 10.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.3 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 2.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 1.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 2.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 47.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.3 | 3.4 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 14.0 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 1.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 1.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 2.5 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 0.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 1.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 20.4 | GO:0031267 | small GTPase binding(GO:0031267) |
0.3 | 0.8 | GO:0015114 | inorganic phosphate transmembrane transporter activity(GO:0005315) phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 47.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 1.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.3 | 3.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.0 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.3 | 6.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 2.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 2.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 1.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 2.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 3.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 2.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 2.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 2.4 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 1.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 1.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 35.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 3.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 43.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 4.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 29.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 0.9 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 4.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 5.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 6.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 3.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 3.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 3.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 25.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 1.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 2.3 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.2 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 11.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 1.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 1.8 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 3.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
0.2 | 1.8 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 8.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 4.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 21.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 18.1 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 4.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 3.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 2.0 | GO:0016829 | lyase activity(GO:0016829) |
0.2 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 3.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 2.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 11.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 2.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 2.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 1.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.6 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 36.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 1.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 7.3 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 3.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 3.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 1.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 2.0 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 9.6 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 12.4 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 1.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 1.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.6 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.9 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 2.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.1 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.7 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 1.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 40.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 15.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 2.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0070990 | snRNP binding(GO:0070990) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 32.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.1 | 90.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.8 | 32.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.5 | 20.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.5 | 34.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.5 | 22.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.4 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.3 | 11.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.3 | 33.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.3 | 19.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.3 | 29.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.3 | 16.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.2 | 65.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.2 | 15.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.2 | 36.0 | PID ARF6 PATHWAY | Arf6 signaling events |
1.1 | 27.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.1 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.1 | 3.3 | ST STAT3 PATHWAY | STAT3 Pathway |
1.1 | 12.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.0 | 19.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.0 | 5.1 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.0 | 23.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.0 | 23.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.0 | 5.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.0 | 15.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.9 | 1.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.9 | 17.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.9 | 7.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 4.5 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 4.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 6.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.9 | 24.2 | PID FOXO PATHWAY | FoxO family signaling |
0.8 | 25.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.8 | 12.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.8 | 49.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.8 | 6.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 4.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.8 | 16.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.8 | 1.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 3.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.8 | 8.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.7 | 5.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.7 | 5.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.7 | 10.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.7 | 8.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.7 | 11.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 16.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 9.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.7 | 4.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 12.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.7 | 26.8 | PID P73PATHWAY | p73 transcription factor network |
0.7 | 8.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 8.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 4.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 5.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.7 | 21.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 2.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 2.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 3.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.6 | 1.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 3.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.6 | 8.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 8.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.6 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.6 | 13.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 9.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 17.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.6 | 11.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.6 | 6.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 10.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.6 | 1.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 11.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 3.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 7.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 7.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 5.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 9.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 10.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.5 | 18.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 1.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 1.5 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 22.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 3.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 9.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.5 | 3.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 8.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 6.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 11.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 3.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 10.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 7.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 10.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 27.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 7.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 4.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 3.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 0.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 5.2 | PID ATM PATHWAY | ATM pathway |
0.4 | 8.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 9.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 1.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 6.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 4.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 3.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 3.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 7.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 7.5 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 2.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 52.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 4.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 2.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 8.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 3.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 4.1 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 4.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 4.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 1.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 4.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 2.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 16.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 12.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 71.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
4.3 | 34.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.8 | 27.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.6 | 21.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.3 | 2.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
2.1 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.0 | 58.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
2.0 | 20.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.8 | 56.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.8 | 19.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.7 | 13.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.6 | 23.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.6 | 3.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.5 | 14.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.5 | 16.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.5 | 1.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
1.4 | 8.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.4 | 2.8 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
1.4 | 60.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.3 | 13.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.3 | 4.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.3 | 11.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.3 | 3.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.3 | 13.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 24.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.3 | 38.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.3 | 17.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.2 | 12.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.2 | 6.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.2 | 11.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.2 | 11.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.2 | 30.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.2 | 2.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.2 | 26.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.2 | 13.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.2 | 7.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.1 | 4.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.1 | 3.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.1 | 25.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.1 | 10.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.1 | 29.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.1 | 15.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.1 | 13.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.1 | 15.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 19.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.1 | 12.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.0 | 18.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.0 | 9.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.0 | 11.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.0 | 22.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.0 | 17.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.0 | 7.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.0 | 10.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.0 | 18.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.0 | 7.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.9 | 8.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.9 | 40.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.9 | 6.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 15.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 6.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.9 | 5.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.9 | 3.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.8 | 0.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.8 | 12.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.8 | 12.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 7.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 1.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.8 | 6.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.8 | 7.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 2.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.8 | 10.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 9.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.8 | 7.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.8 | 6.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 2.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 10.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.8 | 19.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 8.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 10.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.8 | 7.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 6.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 11.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 21.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.7 | 8.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 2.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 17.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 2.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 5.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.7 | 7.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 13.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 2.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.7 | 11.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 6.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 5.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 4.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.7 | 13.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.7 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 5.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.7 | 9.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.7 | 3.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.7 | 8.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.7 | 12.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.7 | 5.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 14.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.6 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 5.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 12.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.6 | 7.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 7.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.6 | 16.0 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.6 | 38.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 8.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.6 | 7.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.6 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 11.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 0.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.6 | 24.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 4.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.5 | 5.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 2.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 13.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 0.5 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.5 | 9.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 12.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 7.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.5 | 1.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 7.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 3.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 13.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.5 | 15.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 4.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.5 | 16.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.5 | 18.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.5 | 30.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 1.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 51.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 7.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 5.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.4 | 9.9 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.4 | 4.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 6.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 15.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 19.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 5.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.4 | 3.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 4.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 3.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.4 | 4.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 1.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 5.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 3.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 3.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 5.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 4.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 4.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 5.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 4.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.4 | 22.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 4.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 12.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 2.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 1.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 4.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 11.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 0.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 7.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 7.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 7.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 19.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 2.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 1.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 4.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 1.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 6.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 4.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 6.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 3.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 1.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 4.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.3 | 1.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 0.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 5.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 9.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 7.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 24.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 17.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 2.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 2.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 9.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 10.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |